PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 1, 1991Annals of Internal Medicine191 citations

Serum Cholesterol as a Prognostic Factor after Myocardial Infarction: The Framingham Study

View Full Paper
NWNathan D. WongPWPeter W.F. WilsonWKWilliam B. Kannel

Structured PICO

Does elevated serum cholesterol increase the risk of reinfarction, coronary heart disease death, and all-cause mortality in patients who have recovered from a myocardial infarction?

P
Population
374 adults (260 men, 114 women), 33 to 88 years of age (mean age, 62 years), who had a history of myocardial infarction, from the Framingham Heart Study.
I
Intervention
High serum cholesterol levels (≥ 7.11 mmol/L or 275 mg/dL) measured approximately 1 year after recovery from initial myocardial infarction
C
Comparator
Low serum cholesterol levels (< 5.17 mmol/L or 200 mg/dL)
O
Outcome
Reinfarction, death from coronary heart disease, and all-cause mortalityhard clinical

Elevated serum cholesterol after myocardial infarction is a strong prognostic factor for long-term reinfarction, coronary heart disease death, and all-cause mortality, supporting the role of lipid management in this population.

Abstract

OBJECTIVE: To determine the relation between serum cholesterol levels and the long-term risk for reinfarction, death from coronary heart disease, and all-cause mortality in persons who recover from myocardial infarction. DESIGN: Prospective, longitudinal study. SETTING: A geographically defined population-based cohort of adults participating in the Framingham Heart Study. PATIENTS: Men (n = 260) and women (n = 114), 33 to 88 years of age (mean age, 62 years), who had a history of myocardial infarction. MEASUREMENTS: A complete physical examination, including electrocardiographic evaluation, blood pressure measurement, height and weight measurements, determination of smoking habits, and casual determinations of blood glucose and serum cholesterol, was done approximately 1 year after recovery from initial myocardial infarction. Patients were followed after infarction for the occurrence of reinfarction or death (mean follow-up, 10.5 years; range, 0.8 to 31.6 years). MAIN RESULTS: The mean cholesterol level after infarction was 5.21 mmol/L (242.8 mg/dL); 20% of patients had levels below 5.17 mmol/L (200 mg/dL), and 22% had levels of 7.11 mmol/L (275 mg/dL) or more. Compared with patients who had cholesterol levels below 5.17 mmol/L, patients with levels of 7.11 mmol/L or more were at increased risk for reinfarction (relative risk, 3.8; 95% Cl, 1.6 to 8.7), death from coronary heart disease (relative risk, 2.6; Cl, 1.4 to 4.8), and all-cause mortality (relative risk, 1.9; Cl, 1.2 to 2.9) based on multivariate Cox regression analyses adjusted for other coronary risk factors. Intermediate cholesterol levels (5.17 mmol/L to 7.11 mmol/L) were generally not associated with increased risk. The association between elevated serum cholesterol and increased risk was strongest in men; however, elevated cholesterol levels were found to be most strongly related to death from coronary disease and to all-cause mortality in persons who were 65 years of age or more. CONCLUSIONS: Patients who have recovered from a myocardial infarction and who have high cholesterol levels are at an increased long-term risk for reinfarction, death from coronary heart disease, and all-cause mortality. Our results confirm the prognostic value of cholesterol levels measured after myocardial infarction and support the role of lipid management in this population.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wong et al. (1991) studied this question.

synapsesocial.com/papers/6a2136f7a2a97f3a085ad197https://doi.org/10.7326/0003-4819-115-9-687
Ask AI
Helpful
Bookmark
Share
View Full Paper